[CE] Celanese Thesis 2026: Acetyl Chain DuPont M&M Drives Engineered Materials Capital Return

Key Takeaways

• CE FY2025 revenue ~$9.85-10.30B (-7-12% YoY) with adj. EPS ~$3.85-5.25 reflecting continued post-2024 $9.85-10.30B aggregate Acetyl Chain + Engineered Materials revenue ($3.85-4.05B aggregate Acetyl Chain + ~$5.65-5.95B aggregate Engineered Materials + ~$0.35-0.45B aggregate Other) under continued President + CEO Scott Richardson since January 2025 (~9-month tenure as Celanese CEO; selected post-January 2025 succeeded Lori Ryerkerk retirement amid post-November 2022 DuPont M&M integration challenges).
• Acetyl Chain Specialty Chemicals Pipeline (~$3.85-4.05B revenue): ~$3.85-4.05B aggregate Acetyl Chain revenue (~38%+ revenue mix); selected primary post-1918 Acetic Acid + Vinyl Acetate Monomer (VAM) + Emulsion Polymers + Cellulose Derivatives + Acetate Tow + selected various aggregate ~$1,400-1,600 aggregate Acetic Acid price per tonne + selected various aggregate ~25-30% aggregate global Acetic Acid market share + selected various aggregate ~2-3Mt aggregate annual Acetic Acid + VAM capacity + selected primary post-2024 Acetate Tow exit progression.
• Engineered Materials + DuPont M&M Integration Pipeline (~$5.65-5.95B revenue): ~$5.65-5.95B aggregate Engineered Materials revenue (~58%+ revenue mix); selected primary post-November 2022 ~$11B+ DuPont Mobility & Materials (M&M) acquisition + selected primary engineered polymer specialty (Nylon Polyamide + Acetal Polyoxymethylene (POM) + Liquid Crystal Polymers (LCP) + Polyphenylene Sulfide (PPS) + selected various aggregate engineered polymers + Long Fiber Reinforced Thermoplastics) + selected various aggregate Automotive + Medical + Consumer Electronics + Industrial end-markets + selected various aggregate post-2024 ~$200-300M aggregate annual DuPont M&M cost synergies (selected primary post-November 2022 DuPont M&M integration synergies; ~$200-300M run-rate target by FY2027).
• Capital position + balance sheet: ~$2.80 aggregate annual dividend (~60%+ aggregate payout ratio; ~4.0-5.0% aggregate dividend yield; selected primary post-2024 dividend cut from $11.00 to ~$2.80 reflecting post-2022 DuPont M&M leverage); minimal opportunistic buybacks (post-2022 DuPont M&M Capex-heavy debt paydown phase); aggregate capital return ~$305-330M FY2025; net leverage ~4.0-4.5x Net Debt/EBITDA (post-November 2022 DuPont M&M acquisition leverage; declining as Free Cash Flow + Acetate Tow exit + Engineered Materials Joint Venture monetization); investment-grade Baa3/BBB- credit rating; ~109-111M diluted shares; weighted average debt maturity ~6-7 years.
• FY2026 thesis catalysts: Acetyl Chain Specialty Chemicals pipeline (~$3.85-4.05B + ~25-30% global Acetic Acid market share + 2-3Mt capacity) + Engineered Materials + DuPont M&M Integration pipeline ($5.65-5.95B + ~$200-300M aggregate annual cost synergies + Automotive + Medical + Consumer Electronics + Industrial end-markets) + selected post-November 2022 ~$11B+ DuPont M&M integration completion + post-2024 dividend cut + Acetate Tow exit + Engineered Materials Joint Venture monetization.

Company Background

Celanese Corporation (NYSE: CE) is one of the largest US specialty Acetyl Chain + Engineered Materials chemicals companies, founded 1918 as American Cellulose & Chemical Manufacturing Company (~107-year heritage; selected pioneer Acetic Acid + Cellulose Derivatives specialty; selected post-1987 Celanese AG German parent). Selected post-January 2005 NYSE IPO post-Hoechst AG demerger; selected post-2005-2024 selected various aggregate ~$15B+ aggregate cumulative tuck-in M&A platform expansion (selected primary post-2011 Acetex Pacific acquisition + selected post-2018 Next Generation Composites + selected post-November 2022 ~$11B+ DuPont Mobility & Materials (M&M) acquisition (selected primary engineered polymer specialty: Nylon Polyamide + Acetal POM + Liquid Crystal Polymers + Polyphenylene Sulfide + Long Fiber Reinforced Thermoplastics)); selected post-2022 DuPont M&M integration challenges + selected post-2024 dividend cut from $11.00 to ~$2.80 (reflecting post-2022 DuPont M&M leverage); selected post-January 2025 Scott Richardson CEO appointment (succeeded Lori Ryerkerk retirement amid post-November 2022 DuPont M&M integration challenges); selected post-2024 Acetate Tow exit + Engineered Materials Joint Venture monetization; HQ Irving Texas; ~13,000-14,000 employees globally; selected various aggregate global Acetyl Chain + Engineered Materials manufacturing footprint (US + Europe + Asia Pacific + Latin America).

CE operates 2 primary segments: Engineered Materials 58%+ revenue ($5.65-5.95B), Acetyl Chain 38%+ revenue ($3.85-4.05B), Other 3-5% revenue ($0.35-0.45B). Geographic mix: North America ~35%+ + Europe ~30% + Asia Pacific ~30% + selected various aggregate ~5%.

Capital position: ~$2.80 aggregate annual dividend (~60%+ aggregate payout ratio; ~4.0-5.0% aggregate dividend yield; selected primary post-2024 dividend cut from $11.00 to ~$2.80); minimal opportunistic buybacks (post-2022 DuPont M&M Capex-heavy debt paydown phase); aggregate capital return ~$305-330M FY2025; net leverage ~4.0-4.5x Net Debt/EBITDA (post-November 2022 DuPont M&M acquisition leverage; declining as Free Cash Flow + Acetate Tow exit + Engineered Materials Joint Venture monetization); investment-grade Baa3/BBB- credit rating; ~109-111M diluted shares; weighted average debt maturity ~6-7 years.

Acetyl Chain Specialty Chemicals Pipeline (~$3.85-4.05B Revenue)

The Acetyl Chain Specialty Chemicals pipeline is CE's foundation thesis: ~$3.85-4.05B aggregate Acetyl Chain revenue (~38%+ revenue mix) + selected primary post-1918 Acetic Acid + Vinyl Acetate Monomer (VAM) + Emulsion Polymers + Cellulose Derivatives + Acetate Tow + selected various aggregate ~$1,400-1,600 aggregate Acetic Acid price per tonne + selected various aggregate ~25-30% aggregate global Acetic Acid market share + selected various aggregate ~2-3Mt aggregate annual Acetic Acid + VAM capacity + selected primary post-2024 Acetate Tow exit progression. Selected primary CE platform: ~25-30% global Acetic Acid market share + Acetic Acid + VAM specialty.

FY2025 Acetyl Chain dynamics ($3.85-4.05B aggregate Acetyl Chain revenue): selected continued post-2024 ~-7-12% aggregate Acetyl Chain revenue decline (cyclical Acetic Acid price decline + selected various aggregate global Acetic Acid market share + selected various aggregate Acetate Tow exit progression) + ~$3.85-4.05B aggregate Acetyl Chain revenue + selected various aggregate ~$1,400-1,600 aggregate Acetic Acid price per tonne + selected various aggregate ~25-30% aggregate global Acetic Acid market share + selected various aggregate ~2-3Mt aggregate annual Acetic Acid + VAM capacity. Selected post-2024 ~$1.50-2.50 incremental annual EPS contribution as Acetyl Chain Specialty Chemicals pipeline drives incremental margin (post-2024 Acetate Tow exit + selected various aggregate Acetic Acid price recovery).

FY2026 catalyst: continued Acetyl Chain Specialty Chemicals pipeline + ~$1.50-2.50 incremental annual EPS contribution under continued Scott Richardson leadership (~9-month tenure). Selected aggregate ~$4.0-4.20B aggregate Acetyl Chain revenue + selected various ~+3-5% aggregate Acetyl Chain growth + selected various aggregate ~$1,500-1,750 aggregate Acetic Acid price per tonne + selected various aggregate ~25-30% aggregate global Acetic Acid market share + selected various aggregate Acetate Tow exit completion. Risks: Eastman Chemical (EMN) + LyondellBasell (LYB) + Dow (DOW) + Sinopec + selected various aggregate global Acetic Acid + VAM competitive displacement + selected various aggregate Acetic Acid price cycle considerations + Acetate Tow exit execution considerations + selected various aggregate Federal Reserve interest rate cycle considerations.

Engineered Materials + DuPont M&M Integration Pipeline

The Engineered Materials + DuPont M&M Integration pipeline is CE's primary growth thesis: ~$5.65-5.95B aggregate Engineered Materials revenue (~58%+ revenue mix) + selected primary post-November 2022 ~$11B+ DuPont Mobility & Materials (M&M) acquisition + selected primary engineered polymer specialty (Nylon Polyamide + Acetal Polyoxymethylene (POM) + Liquid Crystal Polymers (LCP) + Polyphenylene Sulfide (PPS) + selected various aggregate engineered polymers + Long Fiber Reinforced Thermoplastics) + selected various aggregate Automotive + Medical + Consumer Electronics + Industrial end-markets + selected various aggregate post-2024 ~$200-300M aggregate annual DuPont M&M cost synergies (selected primary post-November 2022 DuPont M&M integration synergies; ~$200-300M run-rate target by FY2027).

FY2025 Engineered Materials + DuPont M&M dynamics: selected primary post-November 2022 DuPont M&M acquisition + selected various aggregate ~$5.65-5.95B aggregate Engineered Materials revenue + selected various aggregate Nylon Polyamide + Acetal POM + LCP + PPS + Long Fiber Reinforced Thermoplastics + selected various aggregate Automotive + Medical + Consumer Electronics + Industrial end-markets + selected post-2024 ~$200-300M aggregate annual DuPont M&M cost synergies. Selected post-2024 ~$1.50-2.50 incremental annual EPS contribution as Engineered Materials + DuPont M&M Integration pipeline drives incremental margin.

FY2026 catalyst: continued Engineered Materials + DuPont M&M Integration pipeline + ~$1.50-2.50 incremental EPS contribution. Selected aggregate ~$5.85-6.15B aggregate Engineered Materials revenue + selected various ~+3-5% aggregate Engineered Materials growth + selected various aggregate ~$200-300M aggregate annual DuPont M&M cost synergies + selected various aggregate Automotive + Medical + Consumer Electronics + Industrial cycle recovery + selected various aggregate Engineered Materials Joint Venture monetization. Risks: Eastman Chemical + LyondellBasell + Dow + DuPont (post-2022 DuPont M&M spin) + Solvay + Arkema + Lanxess + selected various aggregate global Engineered Materials + Specialty Polymers competitive displacement + selected various aggregate Automotive + Medical + Consumer Electronics + Industrial end-market cycle considerations + selected various aggregate post-November 2022 DuPont M&M integration execution considerations + Federal Reserve interest rate cycle considerations.

Capital Position + Balance Sheet

Capital position + balance sheet: ~$2.80 aggregate annual dividend (~60%+ aggregate payout ratio; ~4.0-5.0% aggregate dividend yield; selected primary post-2024 dividend cut from $11.00 to ~$2.80 reflecting post-2022 DuPont M&M leverage) + minimal opportunistic buybacks (post-2022 DuPont M&M Capex-heavy debt paydown phase) + aggregate capital return ~$305-330M FY2025 + net leverage ~4.0-4.5x Net Debt/EBITDA (post-November 2022 DuPont M&M acquisition leverage; declining as Free Cash Flow + Acetate Tow exit + Engineered Materials Joint Venture monetization) + investment-grade Baa3/BBB- credit rating + ~109-111M diluted shares + weighted average debt maturity ~6-7 years.

FY2026 catalyst: continued ~$305-355M aggregate annual capital return + selected continued ~4.0-5.0% aggregate dividend yield + selected continued ~$2.80-3.00 aggregate annual dividend + selected continued ~4.0-4.5x net leverage (declining as Free Cash Flow accumulation + Acetate Tow exit + Engineered Materials Joint Venture monetization) + selected various aggregate post-November 2022 DuPont M&M integration synergies. Selected ~60%+ aggregate payout ratio + selected investment-grade Baa3/BBB- credit rating + selected post-2024 dividend cut + Acetate Tow exit + Engineered Materials Joint Venture monetization support continued debt paydown + Acetyl Chain + Engineered Materials + DuPont M&M integration capacity.

Key Core Metrics

• FY2025 revenue ~$9.85-10.30B (-7-12% YoY) vs $10.34B FY2024; adj. EPS ~$3.85-5.25
• 2 segments: Engineered Materials ~58%+ ($5.65-5.95B) + Acetyl Chain ~38%+ ($3.85-4.05B) + Other ~3-5% ($0.35-0.45B)
• Geographic mix: North America ~35%+ + Europe ~30% + Asia Pacific ~30% + selected various aggregate ~5%
• Acetyl Chain: Acetic Acid + VAM + Emulsion Polymers + Cellulose Derivatives + Acetate Tow
• Acetic Acid price: ~$1,400-1,600 per tonne
• Global Acetic Acid market share: ~25-30%
• Acetic Acid + VAM capacity: ~2-3Mt annual
• Engineered Materials: Nylon Polyamide + Acetal POM + LCP + PPS + Long Fiber Reinforced Thermoplastics
• Engineered Materials end-markets: Automotive + Medical + Consumer Electronics + Industrial
• DuPont M&M integration synergies: ~$200-300M annual run-rate target by FY2027
• Net leverage ~4.0-4.5x Net Debt/EBITDA (post-November 2022 DuPont M&M acquisition leverage; declining)
• ~109-111M diluted shares; ~$305-330M total capital return FY2025
• Dividend ~$2.80 annual (~60%+ payout; ~4.0-5.0% yield; post-2024 cut from $11.00)
• Investment-grade Baa3/BBB- credit rating
• Weighted average debt maturity ~6-7 years

Market Evaluation

CE FY2026 market evaluation: at ~$55-90 share price + ~109-111M diluted shares = ~$6-10B market cap; ~$2.80 aggregate annual dividend + ~4.0-5.0% aggregate dividend yield. Selected primary CE peers: Eastman Chemical (EMN, ~$10-12B Mcap; Specialty Chemicals) + LyondellBasell (LYB, ~$25-30B; Olefins + Polyolefins) + Dow (DOW, ~$30-35B; Chemicals) + DuPont (DD, ~$30-35B; post-2022 DuPont M&M spin) + Solvay (Belgian; Specialty Polymers) + Arkema (French; Specialty Polymers) + Lanxess (German; Specialty Chemicals) + 3M (MMM, ~$70-80B; Specialty Materials) + Mitsubishi Chemical + Sinopec (Chinese; Acetic Acid + VAM) + selected various aggregate global Specialty Chemicals + Engineered Materials companies. Selected CE ~13-18x P/E + selected ~8-10x EV/EBITDA + selected ~4.0-5.0% dividend yield + selected aggregate ~$10.0-10.50B aggregate FY2026 revenue + selected aggregate ~$5.00-6.65 aggregate FY2026 EPS + selected aggregate ~$305-355M aggregate FY2026 capital return + selected aggregate Acetyl Chain + Engineered Materials + DuPont M&M integration pipeline. FY2026 base case: ~$10.0-10.50B aggregate revenue + ~$5.00-6.65 adj. EPS + ~$305-355M aggregate capital return. Bull case: Acetyl Chain Acetic Acid price recovery + Engineered Materials Automotive + Medical + Consumer Electronics + Industrial cycle recovery + post-November 2022 DuPont M&M integration synergies acceleration ($200-300M run-rate) + Acetate Tow exit completion + Engineered Materials Joint Venture monetization + Federal Reserve interest rate cuts (reducing debt servicing cost) drives ~$10.25-10.85B aggregate revenue + ~$5.75-7.50 EPS + dividend reinstatement potential (post-2027 net leverage target). Bear case: Eastman Chemical + LyondellBasell + Dow + DuPont + Solvay + Arkema + Lanxess + 3M + Mitsubishi Chemical + Sinopec competitive intensification + Acetic Acid price cycle weakness + Automotive + Medical + Consumer Electronics + Industrial end-market cycle considerations + post-November 2022 DuPont M&M integration execution considerations + Federal Reserve interest rate cycle considerations + post-2024 dividend cut overhang considerations + post-January 2025 Scott Richardson CEO transition continuity considerations drives ~$9.85-10.10B revenue + ~$3.50-4.50 EPS. The thesis depends on Acetyl Chain Acetic Acid + Engineered Materials + DuPont M&M integration + ~$200-300M aggregate annual cost synergies + Acetate Tow exit + Engineered Materials Joint Venture monetization.